| Financial Year |
March 31 2023 |
| Monetary Funds |
1,145,973,401.21 |
| Held-for-trading Financial Assets |
21,633,884.77 |
| Notes Receivable |
96,527,412.57 |
| Accounts Receivable |
1,844,001,727.03 |
| Advances to Suppliers |
207,347,612.07 |
| Other Receivables |
47,173,757.66 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
734,246,491.68 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
12,445,273.17 |
| Total Current Assets |
4,301,761,733.68 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
181,024,756.70 |
| Investment Properties |
55,013,536.82 |
| Fixed Assetes |
178,104,203.47 |
| Under-construction Projects |
94,242,379.08 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
55,051,301.14 |
| R&D expenses |
-- |
| Goodwill |
694,759.16 |
| Long-Term Deferred and Prepaid Expenses |
6,895,148.82 |
| Deferred Income Tax Assets |
41,143,664.87 |
| Other Non-Current Assets |
-- |
| Sub-Total of Non-Current Assets |
781,990,703.08 |
| Total Assets |
5,083,752,436.76 |
| Short-Term Loans |
1,157,639,640.10 |
| Trading Financial liabilities |
-- |
| Notes Payable |
414,554,323.80 |
| Accounts Payable |
599,139,748.35 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
46,095,426.47 |
| Taxes Payable |
68,083,859.83 |
| Interest Payable |
-- |
| Dividend Payable |
980,000.00 |
| Other payables |
91,701,071.79 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
26,244,545.46 |
| Other Current Liabilities |
33,921,811.41 |
| Sub-Total of Current Liabilities |
2,538,325,243.19 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
1,345,508.75 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
147,963,641.55 |
| Total Liabilities |
2,686,288,884.74 |
| Paid-In Capital(Or Share Stock) |
525,100,000.00 |
| Capital Surplus |
412,435,038.59 |
| Surplus Reserve |
143,928,001.86 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
1,341,841,536.61 |
| Minority Stockholder's Interest |
-26,699,088.50 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
2,424,162,640.52 |
| Owner's Equity（Stockholder's Equity） |
2,397,463,552.02 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
5,083,752,436.76 |
